NewsRx

Search our medical news database

Corporate Update

Pronova Biocare sale announced

Published in Health and Medicine Week, January 19th, 2004

Norsk Hydro has entered into an agreement with the Norwegian industrial company Ferd concerning sale of 80.1% of the wholly owned subsidiary Pronova Biocare.

Pronova Biocare develops, produces and sells marine omega-3 fatty acids. There are three equal business areas: drugs, consumer brands and industry sales. Pronova Biocare has production facilities at Sandefjord and Alesund, Norway, main markets are the European Union and the U.S. The company has developed Omacor, the first drug entirely developed in Norway. It is based on omega-3 and holds approval in several European countries for medical treatment of myocardial infarction and other cardiovascular diseases.

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook